Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Crema co-founder details expansion experiment at Thinking Bigger breakfast
Crema’s work is all about proximity, said George Brooks, seeking to clarify potential misperceptions about the digital product agency’s foray into markets outside Kansas City. “We’ve been running an experiment,” the Crema co-founder told a crowd at Thinking Bigger Business Media’s recent Big Breakfast. “We’re from Kansas City, but probably 80 percent of our clients…
Techweek 100 list released: Dozens of KC’s top cultivators, ambassadors and innovators
Techweek Kansas City on Friday released its Techweek 100 list of the premier leaders pushing innovation in Kansas City. The collection of cultivators, ambassadors and innovators is a who’s who of familiar names across the startup, entrepreneurship and tech communities. Released in the runup to Techweek KC’s Oct. 8-12 festivities, the list isn’t a ranking,…
Not high-growth or a tech startup? AltCap Your Biz $10K prize could be the boost you need
A $10,000 prize can mean a world of difference for the right entrepreneurial dream, said Davin Gordon. “There’s not a ton of opportunities for small businesses to not only pitch their business and go through that process, but actually have an opportunity to win some money,” he said. Entering its fourth year on the startup…
River Watch Beef envisions pure range of ‘farm-to-fork’ products delivered to your door
The beef industry is broken, said Chris Kovac, sitting just an ironic stone’s throw away from the historic Kansas City Stockyards. “We should all educate ourselves on what we’re eating and who we’re buying our food from,” the founder of River Watch Beef said, impassioned as he shared his concern for the health of consumers.…